Fumie Griego is head of global public affairs at Takeda Pharmaceuticals. She is responsible for engaging global policy stakeholders to advance patient-centered policy solutions to accelerate equitable global access to innovative life-transforming medicines and vaccines. She also leads Takeda’s global CSR program and partnership strategy.
Prior to joining Takeda, Dr. Griego was deputy director general and chief operating officer at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva, Switzerland (2017–2023). Previously, she was head of global oncology policy and strategy, global government affairs and policy at Merck KGaA (2016–2017) and vice president for international health policy at Pharmaceutical Research and Manufacturers of America (PhRMA) in Washington, D.C. (2011–2016). Prior to joining PhRMA, Dr. Griego was a senior economist in the White House Office of Management and Budget, where she provided senior U.S. policy officials in both the Bush and Obama administrations with policy advice on a range of health policy issues (2002–2011).
Dr. Griego holds a Ph.D. in health policy from Harvard University and bachelor’s and master’s degrees in earth systems (concentration in environmental economics and policy) from Stanford University.
